03/16/2023

22nd Annual General Meeting of Shareholders Measures to Prevent the Spread of Covid 19

03/13/2023

Impacts of Silicon Valley Bank closure

03/02/2023

GNI Group summary Q&A from full-year 2022 financial results analyst call and other recent inquiries

01/13/2023

Resuming normal office operations

01/11/2023

2023 New Year Greeting

01/04/2023

FAQ for Our Disclosure on December 27, 2022, "GNI Group and Catalyst Biosciences Signed Agreements to Advance Liver Fibrosis Drug Development"